$14.23
-1.22%
N/A-$0.18
헬스케어
의료 - 요양 시설
NASDAQ
활발히 거래 중
EUDA Health Holdings Limited는 주로 싱가포르, 말레이시아 및 중국에서 비침습적 의료 서비스를 제공하는 회사입니다. 이 회사는 바이오에너지 캐빈 요법 패키지, 제3자 치료 ...
EUDA Health Holdings Limited는 주로 싱가포르, 말레이시아 및 중국에서 비침습적 의료 서비스를 제공하는 회사입니다. 이 회사는 바이오에너지 캐빈 요법 패키지, 제3자 치료 ...
EUDA Health Holdings Limited (EUDA) is positioned as a healthcare-technology company providing non-invasive healthcare services and digital healthcare capabilities, with operations focused largely in Singapore and other parts of Asia, including Malaysia and China. The company’s stated purpose and market positioning emphasize improving access to healthcare through technology—particularly by facilitating online medical consultations for routine, non-urgent health concerns. From a business and operating perspective, EUDA’s model blends (1) medical services delivered through an organized service platform and (2) technology-driven engagement and consultation workflows. This combination typically means the company must coordinate clinical/medical delivery (e.g., qualified healthcare professionals), customer-facing experience (e.g., user onboarding, symptom/health history intake, consultation booking), and supporting back-office systems (e.g., scheduling, documentation, billing, and compliance). The company’s focus on “routine, non-urgent” care suggests an emphasis on scalable, standardized consultation pathways rather than high-acuity hospital services. Product and services scope is described in the sources as an innovative platform enabling online medical consultations and a broader Southeast Asian digital healthcare ecosystem. Such ecosystems generally include patient interaction, clinical triage/consultation, and potentially downstream healthcare management activities (depending on regional regulatory frameworks). EUDA’s market footprint—Singapore, Malaysia, and China—also implies it must adapt service delivery and operational processes to local healthcare rules and partner networks. In terms of costs and cost drivers (BOM and operating cost structure at a practical level), digital healthcare platforms usually incur recurring technology and personnel costs (software/platform maintenance, cybersecurity, data systems, customer support) alongside clinical operations costs (medical staff, consultation workflows, quality assurance). The company also needs distribution and compliance overheads across jurisdictions. The provided financial snapshot shows profitability pressure at the trailing-twelve-month level (negative operating margins and net profit margin), which is consistent with early-stage scaling, investment in operations/technology, or higher fixed costs relative to revenue. The dataset indicates revenue-related profitability metrics such as gross profit margin around the high 40% range, while operating and net margins are negative (e.g., operating profit margin and net profit margin shown as negative). It also shows liquidity/working-capital stress signals (e.g., current ratio and working capital figures in the dataset), which can matter for a company balancing growth investments and operating needs. Key people disclosed in the sources include CEO Alfred Lim (and board-level references to Dr. Kelvin Chen as Chief Executive Officer in some materials). EUDA’s leadership and governance structure therefore appears to include a board with independent directors alongside executive leadership. Overall, EUDA aims to deliver accessible, tech-enabled non-invasive healthcare services across Southeast Asia and adjacent markets, targeting segments that benefit from convenient online consultations. Its near-term “wishes” as implied by the market narrative are likely centered on scaling service adoption, improving unit economics, and sustaining compliance-ready operations while continuing to develop and operationalize its digital healthcare ecosystem.